Counterfeit Injectables in Europe: How They Enter Clinics Undetected

For aesthetic practitioners across Europe, patient safety and clinical excellence remain the highest priorities. The growing demand for dermal fillers has unfortunately given rise to a parallel threat: counterfeit and diverted aesthetic injectables. These products can compromise patient safety while exposing clinics to significant legal, financial, and reputational consequences.

Understanding how they enter legitimate supply chains is the first step towards protecting both your patients and your practice.

How Big Is the Grey Market Problem in European Aesthetics?

The grey market for aesthetic injectables in Europe is a growing concern, fuelled by the allure of lower prices and often facilitated by sophisticated deception tactics. Although the true scale of the problem is difficult to quantify due to the covert nature of the trade, regulatory authorities and industry organisations consistently report the presence of counterfeit, falsified, and unauthorised aesthetic products within the European market. This includes everything from outright fakes manufactured in unregulated facilities to genuine products diverted from authorised channels and mishandled.

Counterfeit and diverted injectables represent a Europe-wide challenge rather than an isolated local issue. Cross-border distribution networks enable these products to move between countries, making them increasingly difficult for regulators and healthcare professionals to detect before they reach clinical practice. The primary driver for practitioners unwittingly engaging with this market is often the promise of cost savings, which can appear attractive in a competitive environment. However, these perceived savings invariably come with an unacceptable level of risk.

Which Products Are Most Frequently Counterfeited and Why

Certain aesthetic injectables are more prone to counterfeiting and diversion due to their high demand, brand recognition and relatively high market value. Dermal fillers, particularly popular hyaluronic acid (HA) brands, are prime targets. Products such as Juvederm, Restylane, and Teosyal frequently appear in counterfeit or diverted forms. Botulinum toxin products also face similar risks.

The reasons are clear:

• High Demand: Globally recognised brands are always in demand, making them attractive for illicit reproduction ;
• Profit Margins: The difference between the legitimate wholesale price and the cost of producing fakes, or acquiring diverted products, offers substantial profits for unauthorised operators ;
• Ease of Replication: While sophisticated, the packaging and appearance of genuine products can be mimicked convincingly enough to deceive an untrained eye ;
• Lack of Direct Verification at Point of Sale: Unlike prescription drugs, aesthetic injectables are often purchased and used in a clinical setting without immediate, rigorous point-of-use verification processes ;

How Diverted Products Enter the EU Supply Chain Undetected

The methods used to introduce counterfeit dermal fillers and diverted products into the legitimate supply chain are increasingly sophisticated.

These can include:

• Online Pharmacies: Many illicit products are sold through websites that appear professional but lack proper authorisation or regulatory oversight. These often promise significantly reduced prices, which should immediately raise a red flag.
• Parallel Imports and Diversion: Genuine products intended for one market, for example outside the EU where prices might be lower, may be illegally imported into another. While the product itself might be authentic, its handling, storage, and traceability can be compromised. This diversion bypasses official regulatory checks and quality assurances.
• Re-packaging and Tampering: In some cases, genuine products may be tampered with, diluted, or even refilled with entirely different, harmful substances, then re-packaged to appear legitimate.
• "Phantom" Companies: Counterfeiters often use fake companies or shell corporations to distribute counterfeit products, making it significantly more difficult to trace their true origin once a transaction has been completed.
• Exploiting Supply Chain Gaps: The complexity of international supply chains offers numerous points where illicit products can be inserted, especially when distributors do not adhere to Good Distribution Practices (GDP).

The Real Risks — Clinical, Legal and Financial

Purchasing products outside legitimate distribution channels exposes practitioners to risks that extend far beyond the initial purchase price.

What Happens When a Compromised Product Causes an Adverse Event

The most immediate and severe risks are to patient health and safety. Counterfeit or diverted injectables often:

• Contain Unknown or Harmful Substances: Counterfeit injectables may contain industrial-grade silicone, non-sterile water, undeclared substances, or other hazardous contaminants. These products can lead to serious adverse events, including severe inflammatory or allergic reactions, infections, tissue necrosis, vascular occlusion, permanent vision loss, and, in rare cases, life-threatening complications.
• Have Incorrect Concentrations: If the active ingredient is present, its concentration may be incorrect, leading to unpredictable results and lack of efficacy.
• Are Non-Sterile: Products manufactured in unregulated environments often lack sterility, posing a high risk of bacterial, viral, or fungal infections at the injection site.
• Lack Traceability: In the event of an adverse reaction, identifying the source of a counterfeit product is nearly impossible, hindering proper medical intervention and product recall efforts.
• Cause Disfigurement: Compromised products can lead to permanent disfigurement, granulomas, scarring, and long-term psychological distress for patients.

Why Your Insurance May Not Cover Non-Authorised Product Claims

Beyond the immediate clinical fallout, using non-authorised products can have devastating legal and financial repercussions for your practice.

• Voided Insurance Coverage: Most professional indemnity insurance policies explicitly state that coverage is null and void if non-authorised, counterfeit, or illegally sourced products are used. This means that if a patient suffers an adverse event from such a product, your insurance will likely refuse to cover legal defence costs or damages.
• Personal Liability: If an insurer determines that a claim involves products sourced outside authorised distribution channels or products that cannot be adequately traced, coverage may be reduced or denied, depending on the policy terms and applicable national legislation. In such cases, practitioners and clinic owners could face substantial legal costs, compensation claims, and significant financial exposure, potentially threatening the long-term viability of their practice.
• Regulatory Penalties: European regulatory authorities take the use of counterfeit, falsified, or non-compliant medical products extremely seriously. Depending on the jurisdiction and the circumstances of the case, practitioners may face regulatory investigations, administrative sanctions, civil liability, or, in the most serious cases, criminal proceedings.
• Reputational Damage: News of adverse events linked to counterfeit products can irreparably damage a practitioner's and clinic's reputation, leading to a complete loss of patient trust and business.
• Brand Association: Being associated with counterfeit products also damages the reputation of legitimate brands and the aesthetic industry as a whole.

How to Identify a Suspect Product on Arrival

Product verification should begin as soon as a shipment is received. Every delivery should be carefully inspected before products are accepted into inventory or used in clinical practice. Staff responsible for receiving, storing, or preparing injectable products should be trained to recognise potential warning signs.

Batch Number Verification: A Practical Approach

While verification procedures differ between manufacturers, every clinic should follow a consistent process before introducing a product into clinical use.

1. Check the Batch Number and Expiry Date

Locate the batch, or lot, number and expiry date on the outer carton and compare them with any corresponding labels on the syringe, blister packaging, or other product components where applicable. Any discrepancy between these identifiers should be treated as a potential warning sign and investigated before the product is used.

2. Inspect the Packaging Carefully

Examine the product for any signs of tampering or inconsistencies. Pay particular attention to:

• Poor print quality ;
• Spelling or grammatical errors ;
• Security seals or tamper-evident features ;
• CE marking and other required regulatory information ;
• Product labels and manufacturer details ;
• Signs of damage, resealing, or repackaging ;

Although counterfeit packaging has become increasingly sophisticated, careful inspection can still reveal important warning signs.

3. Verify the Product's Traceability

Leading manufacturers such as AbbVie (Juvederm), Galderma (Restylane), and Merz Aesthetics (Belotero) incorporate various security and traceability measures into their products. However, verification methods vary by manufacturer and country, and there is generally no universal public database that allows practitioners to authenticate products solely by entering a batch number.

If there is any doubt regarding a product's authenticity or origin, practitioners should contact the manufacturer or the authorised distributor from whom the product was purchased to request verification.

4. Use Digital Authentication Features Where Available

Some manufacturers incorporate QR codes, Data Matrix codes, Unique Device Identifiers (UDI), or other digital traceability features on selected products or packaging. These features should only be relied upon when they originate directly from the manufacturer and form part of the official product identification system. Their presence and functionality vary between brands and markets.

5. Confirm the Supply Chain

Product authenticity cannot be established through packaging inspection alone. The most reliable safeguard remains a fully traceable supply chain. Clinics should retain invoices, delivery notes, and batch records for every injectable product and ensure purchases are made exclusively through authorised distributors.

6. Contact the Manufacturer if in Doubt

Whenever concerns arise regarding a product's batch number, packaging, traceability, or distribution history, practitioners should suspend use immediately and contact the manufacturer's local customer service team or the authorised distributor. Manufacturers can often assist in confirming whether a product originates from an authorised distribution channel and advise on the appropriate next steps.

Crucial Note: Never rely on a verification system provided by the supplier unless it redirects directly to the official manufacturer's website. Counterfeiters can create convincing fake verification sites.

Packaging Red Flags to Check on Every Delivery

Even before batch number verification, several packaging cues can indicate a suspect product:

• Inconsistent Branding: Look for variations in logo placement, font type, colour, or image quality compared to genuine products you've previously received from authorised sources.
• Poor Print Quality: Blurry text, smudged ink, misspellings, or grammatical errors on the packaging or leaflet are strong indicators of counterfeiting.
• Damaged or Tampered Packaging: Bent corners, torn seals, evidence of re-gluing, or any signs that the box has been opened and re-sealed should trigger suspicion.
• Missing or Incorrect Information: Ensure the packaging includes all legally required information for your region, such as CE marks, manufacturer details, batch number, expiry date, and product instructions in local languages.
• Unusual Packaging Materials: Flimsy cardboard, different plastic textures for trays, or unusual syringe designs compared to authentic products.
• Missing or Incorrect Security Features: Many legitimate brands incorporate holograms, watermarks, or other overt and covert security features. Familiarise yourself with these and check for their presence and authenticity.
• "Too Good to Be True" Pricing: If the price is significantly lower than the standard market rate from authorised distributors, it is a major red flag.

How to Vet Any New Supplier Before Placing Your First Order

Choosing the right supplier is one of the most important decisions an aesthetic clinic can make. A reputable distributor provides more than competitive pricing; they ensure product authenticity, full traceability, compliant storage and transport conditions, and the documentation needed to support safe clinical practice.

At RM365, product sourcing is built around authorised supply channels, full traceability, quality assurance, and regulatory compliance, helping healthcare professionals across Europe purchase authentic aesthetic products with confidence.

Three Non Negotiable Questions to Ask

Before placing your first order with any new supplier, ensure you receive clear and documented answers to the following questions.

• How do you ensure full product traceability?
• How are temperature sensitive products stored and transported?
• What is your procedure if there is a product quality concern or manufacturer recall?

What a Trustworthy EU Distributor Provides on Every Shipment

A dependable supplier should consistently deliver:

• Factory-sealed products in their original packaging ;
• Consistent lot numbers and expiry dates ;
• Complete purchase documentation ;
• Appropriate handling and storage throughout delivery ;
• Responsive support before and after purchase ;

Working with a trusted partner helps clinics reduce procurement risks and maintain confidence in every product they use.

Frequently Asked Questions